Clinical trial
Placebo-controlled Randomized Clinical Trial of Alkali Therapy in Patients With Chronic Kidney Disease
NCT01452412 is registered in ClinicalTrials.gov with Albert Einstein College of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Placebo-controlled Randomized Clinical Trial of Alkali Therapy in Patients With Chronic Kidney Disease
- Lead sponsor
- Albert Einstein College of Medicine
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- October 31, 2011
- Completion date
- August 31, 2016
- Enrollment
- 149 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
chronic kidney disease, metabolic acidosis